Not Condition-specific Clinical Trial
Official title:
Promoting Flu Vaccination Through a Mobile Wellness Program
Verified date | October 2016 |
Source | Evidation Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The investigators design a 6-week messaging campaign aimed at promoting flu vaccination
among fully insured members of a national payer that participate in a wellness program
offered by the insurer through a mobile app. Outcomes measured will include uptake in flu
vaccination rate as measured by the insurer and engagement with the campaign through the
app.
The goal of the research is to assess the effectiveness of pervasive computing messaging in
promoting preventative care treatments such as flu shots. An additional goal is that of
quantifying the importance of emphasizing incentives to increase efficacy of the messages.
Status | Enrolling by invitation |
Enrollment | 77983 |
Est. completion date | June 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - belongs to fully insured population - continuous health coverage between January 1, 2015 and June 1, 2016 - has downloaded and installed the wellness platform app Exclusion Criteria: - has declined the messaging from the platform |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Evidation Health | Santa Barbara | California |
Lead Sponsor | Collaborator |
---|---|
Evidation Health | Army Research Office (ARO), Defense Advanced Research Projects Agency |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increase in vaccination rate vs control | Increase in vaccination rate of anyone messaged relative to the control condition | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Primary | Increase in vaccination rate of salient vs non-salient | Increase in vaccination rate of those who received salient incentives messages vs those who received generic messages | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Secondary | Decrease in medically attended flu events of messaged vs control | Decrease in observed flu rate for messaged users | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Secondary | Increase in reporting of flu vaccination through wellness app of salient vs non-salient | Increase in reporting vaccination through the wellness program app following messages | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Secondary | Increase in vaccination rate for users messaged within 2 days before of an expected rx pick-up. | Increase in vaccination rate of users messaged within 2 days before an expected Rx pick up from a pharmacy relative to their paired partners. | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Secondary | Increase in message open rate of Salient vs Non-salient arm | Increase in open rate of sent messages through the wellness program app of salient vs non salient arm | Up to 1 week after the end of each of the three batches of the intervention (Oct 1/15/28 2016) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02906410 -
Dynamic Presentation of Calorie Information
|
N/A |